Neurological update: MOG antibody disease

Myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOG-AD) is now recognised as a nosological entity with specific clinical and paraclinical features to aid early diagnosis. Although no age group is exempt, median age of onset is within the fourth decade of life, with optic neuritis being t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wynford-Thomas, Ray, Jacob, Anu, Tomassini, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Neurological Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469662/
https://www.ncbi.nlm.nih.gov/pubmed/30569382
http://dx.doi.org/10.1007/s00415-018-9122-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469662/
https://www.ncbi.nlm.nih.gov/pubmed/30569382
http://dx.doi.org/10.1007/s00415-018-9122-2

Ejemplares similares